C WorldWide Group’s Supernus Pharmaceuticals SUPN Stock Holding History

C WorldWide Group’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-17,325	Closed	-$607K	–	106
2019 Q1	$607K	Hold	17,325	–	–	0.01%	109
2018 Q4	$576K	Sell	17,325 -6,148	-26%	-$264K	0.01%	111
2018 Q3	$1.18M	Sell	23,473 -4,585	-16%	-$226K	0.02%	108
2018 Q2	$1.68M	Sell	28,058 -9,908	-26%	-$513K	0.02%	100
2018 Q1	$1.74M	Sell	37,966 -27,634	-42%	-$1.15M	0.03%	84
2017 Q4	$2.61M	Sell	65,600 -5,543	-8%	-$219K	0.04%	77
2017 Q3	$2.85M	Sell	71,143 -527	-0.7%	-$22.8K	0.04%	81
2017 Q2	$3.09M	Sell	71,670 -64,602	-47%	-$2.3M	0.05%	78
2017 Q1	$4.26M	Buy	136,272 +33,272	+32%	+$892K	0.07%	60
2016 Q4	$2.6M	Sell	103,000 -20,000	-16%	-$447K	0.05%	73
2016 Q3	$3.04M	Hold	123,000	–	–	0.05%	73
2016 Q2	$2.51M	Sell	123,000 -115,000	-48%	-$2.04M	0.05%	67
2016 Q1	$3.63M	Hold	238,000	–	–	0.07%	54
2015 Q4	$3.2M	Sell	238,000 -52,000	-18%	-$804K	0.06%	69
2015 Q3	$4.07M	Hold	290,000	–	–	0.07%	59
2015 Q2	$4.92M	Sell	290,000 -90,000	-24%	-$1.28M	0.07%	60
2015 Q1	$4.59M	Buy	380,000 +250,000	+192%	+$2.36M	0.07%	61
2014 Q4	$1.08M	Buy	+130,000	New	+$1.09M	0.02%	86

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

NPIC

Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return

C WorldWide Group's SUPN Position: Q2 2019 in Review

C WorldWide Group sold out of Supernus Pharmaceuticals (SUPN) in Q2 2019, closing a stake of 17,325 shares — an estimated $607K sold.

C WorldWide Group first reported a position in SUPN in Q4 2014 and held it in 18 quarters. The position peaked at $4.92M in Q2 2015. 272 funds tracked by Wall St. Rank hold SUPN as of Q2 2019.

C WorldWide Group reported no remaining Supernus Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
C WorldWide Group sold 17,325 Supernus Pharmaceuticals shares in Q2 2019, an estimated $607K.
C WorldWide Group first reported a position in Supernus Pharmaceuticals in Q4 2014 and held it in 18 quarters.
C WorldWide Group's Supernus Pharmaceuticals position peaked at $4.92M in Q2 2015.
272 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2019.

Based on C WorldWide Group's 13F filing for Q2 2019, filed 2 Aug 2019.